FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR. Angelo de Claro, Richard Pazdur, Haw-Jyh Chiu et al.|Clinical Cancer Research|2015Cited by 165